10x Genomics Inc (NAS:TXG)
$ 23.95 -0.88 (-3.54%) Market Cap: 2.87 Bil Enterprise Value: 2.69 Bil PE Ratio: 0 PB Ratio: 4.13 GF Score: 75/100

10X Genomics Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript

Aug 11, 2022 / 04:00PM GMT
Release Date Price: $48.32 (+2.94%)
Unidentified Analyst

Hi. For our next panel, we're happy to be hosting 10x with us. We have Serge Saxonov and Justin McAnear. Welcome. And if anyone in the audience would like to take questions, we have iPads up on stage, and there's instructions on your table on how to ask them. So maybe just to start off the things off here.

Questions & Answers

Unidentified Analyst

So the last couple of quarters have been a bit challenging. There was the Omicron wave in Q1. Q2 had some macro headwinds. You also mentioned on your call earlier this week that you experienced slower-than-expected rebound as we emerge from the pandemic environment. So just, I guess, given all this happening in the market and the broader macro picture, could you just start off on what gives you confidence in the single cell market and the opportunity there?

Serge Saxonov
10x Genomics, Inc. - Co-Founder, CEO & Director

Yes. So kind of big picture question. The way that I think about things, first of all, is kind of stepping back and thinking in terms of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot